Feline Herpesvirus: Symptoms, Treatment, and Management

Learn about feline herpesvirus, a common cause of respiratory issues in cats. Our guide covers long-term management, from veterinary care to reducing flare-ups.

Feline herpesvirus type 1 (FHV-1) is one of the most widespread viral infections in domestic cats, responsible for a large share of upper respiratory illness and a major cause of eye disease in the species. Nearly all cats that recover from an initial infection carry the virus for life, with flare-ups triggered by stress or illness that can range from mild sneezing to sight-threatening corneal damage. Understanding how FHV-1 behaves, what signs to watch for, and which treatments actually work gives you a much better shot at keeping a carrier cat comfortable over the long haul.

How Cats Pick Up the Virus

FHV-1 spreads through direct contact with an infected cat’s nasal, oral, or ocular secretions. Shared food bowls, grooming, sneezing droplets, and contaminated hands or clothing all serve as routes. Shelters, catteries, and multi-cat households are hotspots because close quarters make transmission almost inevitable. Research using tissue models shows the virus replicates readily in the respiratory lining and the conjunctiva (the thin tissue covering the inner eyelids), while the cornea itself is a less efficient entry point during initial infection. That distinction matters: the upper airways are the primary battleground during the first bout of illness, with eye involvement often following as secondary inflammation spreads.

Outside a cat’s body, the virus is fragile. Standard household disinfectants, including dilute bleach and many quaternary ammonium products, destroy it quickly on surfaces. This is one reason FHV-1 is less prone to environmental persistence than some other feline pathogens, though fomite transmission (via contaminated objects) can still happen if cleaning is lax.

The Latency Problem

Once a cat recovers from the initial infection, FHV-1 does not leave. It retreats into nerve cells, specifically the trigeminal ganglion, a cluster of sensory neurons near the base of the skull. There the viral DNA sits quietly, evading the immune system because it is not actively producing new virus particles. This is called latency, and it is essentially permanent.

The catch is that the virus can reactivate. Stress is the classic trigger: boarding, surgery, a new pet in the house, corticosteroid treatment, or any illness that suppresses immune function can wake the virus up. When it reactivates, the cat may begin shedding virus again and develop fresh clinical signs. Some cats reactivate frequently; others go years between episodes. There is no reliable way to predict which pattern a given cat will follow, and no treatment currently eliminates the latent virus.

Recognizing the Signs

FHV-1 can show up in several ways, and the picture often depends on whether you are dealing with a first infection or a flare-up in a carrier cat.

Upper Respiratory Signs

The classic presentation is “cat flu”: sneezing, nasal congestion, clear or yellowish nasal discharge, fever, and lethargy. Kittens and immunocompromised cats tend to get hit hardest. In severe cases the nasal passages become so inflamed and clogged that the cat stops eating, partly because cats rely on smell to find food appetizing. Secondary bacterial infections can pile on top, turning clear discharge thick and green.

Eye Disease

Ocular signs are among the most troublesome features of FHV-1. Acute infection often causes conjunctivitis (red, swollen, weepy eyes) along with corneal ulceration and keratitis, both of which can be painful. In kittens whose eyes have not yet opened, the virus can cause pus to build up behind sealed eyelids, sometimes permanently damaging the eye if not drained. Repeated flare-ups of ocular disease are a serious concern: each bout risks additional scarring of the cornea, and over time this progressive damage can lead to blindness.

Skin Lesions

Less commonly, FHV-1 causes ulcerative dermatitis, typically on the face and nose. These crusty, non-healing ulcers can look alarming and are sometimes mistaken for autoimmune skin disease or cancer. Diagnosis requires a biopsy: characteristic intranuclear inclusion bodies in the tissue confirm the virus, though they are not always present. When inclusions are absent but the pattern still looks suspicious, immunohistochemistry is the preferred confirmatory test; PCR alone can produce false positives because so many cats carry latent virus. One case report documented unusually deep ulcerative and necrotic skin lesions confirmed by both PCR and electron microscopy, a reminder that the virus can occasionally cause atypical presentations.

Telling FHV-1 Apart from Other Respiratory Infections

Multiple pathogens cause upper respiratory disease in cats, and clinical signs overlap enough that you cannot reliably tell them apart just by looking. Feline calicivirus (FCV) is the other major viral player, while the bacteria Chlamydia felis and Bordetella bronchiseptica also contribute. A study of cats with upper respiratory disease found that roughly 56% tested positive for FHV-1 and 50% for FCV, with about 36% positive for Chlamydia, and many cats harboring more than one pathogen at a time. A separate survey of European catteries found FHV detection rates roughly double in catteries with ongoing respiratory disease compared to those without, lending weight to the virus’s role as a driver of outbreaks.

The practical upshot: if your cat has sneezing, eye discharge, and fever, FHV-1 is a strong suspect but not the only possibility. Your vet may test for multiple agents simultaneously, and co-infections are common enough that a positive result for one pathogen does not rule out another.

Diagnostic Testing

Confirming an FHV-1 infection usually involves PCR testing on swabs taken from the eyes, nose, or throat. PCR is far more sensitive than traditional virus isolation. One comparison study found that virus isolation caught only about half the positive cases that PCR detected. Another study found substantial agreement between culture and PCR results, though PCR consistently performed better as the front-line test.

There is an important limitation to keep in mind. Because latent carriers can shed virus intermittently, a positive PCR result does not necessarily mean FHV-1 is the cause of the cat’s current problem. Conversely, a negative swab during a quiet period does not rule out latent infection. Veterinarians often treat based on the combination of clinical signs, history, and test results rather than relying on any single diagnostic alone.

Antiviral Treatment

Most antiviral drugs used in cats were originally developed for human herpes simplex viruses. That crossover works because FHV-1 belongs to the same subfamily (alphaherpesviruses), and the drugs target similar steps in viral replication. Even so, not every human herpes drug translates well to cats, and formal efficacy data in feline patients are thinner than you might expect.

Famciclovir is the systemic antiviral with the best-documented track record in cats. A retrospective study of 59 cats treated with oral famciclovir for ocular, respiratory, or skin disease attributed to FHV-1 found that about half showed marked improvement, roughly a third had mild improvement, and about 15% showed no apparent response. Higher doses were associated with faster and more pronounced improvement, and adverse effects were uncommon enough that over 90% of owners reported being satisfied with the treatment. Famciclovir is generally well tolerated, though dosing needs to be carefully calibrated because cats metabolize the drug differently than humans do.

For eye-specific disease, topical antiviral drops or ointments are also used. Options include cidofovir, idoxuridine, and trifluridine, though availability varies by country and some of these need to be compounded by specialty pharmacies. The evidence base for these topical agents leans heavily on lab studies and small clinical series rather than large trials.

Interferon and Immunomodulatory Approaches

Recombinant feline interferon omega has been used in some countries to help the immune system fight FHV-1. A case report described successful treatment of herpes-related facial dermatitis with interferon omega in a cat that had not responded adequately to other therapies. Interferon omega is not available everywhere, and the evidence for its use remains largely anecdotal, consisting mainly of case reports and small case series rather than controlled trials. Where it is available, it tends to be reserved for severe or refractory cases.

The Lysine Myth

For years, L-lysine supplementation was widely recommended by veterinarians and sold in pet stores as a way to reduce herpesvirus flare-ups. The logic was borrowed from early human herpes research suggesting that lysine could interfere with viral replication by competing with the amino acid arginine. It sounded reasonable, and the practice became deeply entrenched.

The evidence, however, does not support it. A systematic review examining the available studies concluded that lysine supplementation is not effective for preventing or treating FHV-1 infection in cats, and raised the possibility that it might even enhance viral replication in some circumstances. Despite this, lysine products remain widely sold and frequently recommended. If your vet still suggests it, the published evidence gives you good reason to ask about alternatives. At best, lysine is harmless but ineffective; at worst, it could make things marginally worse.

Vaccination

FHV-1 vaccination is considered a core vaccine for all cats, typically given as part of the FVRCP combination (feline viral rhinotracheitis, calicivirus, panleukopenia). The vaccine does not prevent infection or eliminate the possibility of a cat becoming a carrier. What it does reliably is reduce the severity of disease if the cat is later exposed. A controlled challenge trial demonstrated that vaccinated cats developed significantly milder clinical signs after FHV-1 exposure, with protection lasting at least three years.

This is an important distinction to communicate to cat owners. Vaccination is genuinely valuable, but it does not create a force field. A vaccinated cat can still catch FHV-1, become a latent carrier, and experience flare-ups. The episodes will just tend to be milder and shorter. Kittens are most vulnerable before they complete their initial vaccine series, which is one reason shelters and breeding catteries see the most severe outbreaks.

Day-to-Day Management of a Carrier Cat

Because there is no cure for latent FHV-1, management revolves around minimizing triggers and treating flare-ups promptly when they happen. Stress reduction is the single most impactful strategy you can control at home. Guidelines for shelter disease prevention emphasize that reducing stress is important not just for general welfare but specifically for minimizing reactivation and shedding of infectious agents like FHV-1.

Practical stress-reduction measures for a household cat include:

  • Stable routine: Cats are creatures of habit. Predictable feeding times, minimal household upheaval, and quiet resting spots help.
  • Resource availability: Enough litter boxes, food stations, and perching spots so cats do not compete, especially in multi-cat homes.
  • Gradual introductions: New pets, new people, or household moves should be introduced slowly.
  • Pheromone products: Synthetic feline facial pheromone diffusers are used by many owners and shelters to reduce general anxiety, though controlled evidence for their effect on FHV-1 specifically is limited.

During a flare-up, supportive care matters as much as medication. A congested cat that stops eating can deteriorate quickly, so keeping food intake up is critical. Warming wet food to release aroma, gently clearing nasal discharge with a damp cloth, and using a humidifier in the room can all help. If the cat stops eating for more than a day or two, your vet may discuss appetite stimulants or assisted feeding.

Hygiene in Multi-Cat Settings

Shelters, foster networks, and multi-cat households face the added challenge of limiting spread between animals. The ABCD (Advisory Board on Cat Diseases) guidelines stress that adequate hygiene, including movement control, barrier nursing practices, and thorough cleaning and disinfection, is essential to reduce transmission from shedding cats to susceptible ones. Because FHV-1 is an enveloped virus, it is relatively easy to kill on surfaces compared to hardier pathogens like feline panleukopenia virus. A 1:32 dilution of household bleach with a 10-minute contact time is effective. The harder challenge is controlling aerosol and direct-contact spread among cats housed in the same airspace.

Isolating new arrivals for a quarantine period, ideally in a separate room with its own ventilation, catches many cases before they spread. Caregivers should change gloves and wash hands between handling different cats, and sick cats should be attended to last during daily rounds to avoid carrying the virus to healthy animals on clothing or skin.

Why FHV-1 Strains Are So Similar

One curious feature of FHV-1 is its remarkably low genetic diversity. Genomic comparisons of isolates collected over decades and across multiple continents found that the total genetic distance between strains was under 0.1%. Another study examining historical and contemporary isolates found some that were completely identical at the nucleotide level, while the most divergent pair differed by only 83 single-letter changes across the entire genome.

This genetic uniformity has practical implications. It means that vaccines developed against one strain offer broad cross-protection, since there is no meaningful antigenic variation for the virus to hide behind. It also means that diagnostic PCR tests are reliably sensitive across geographic regions. The flip side is that this stability gives researchers fewer genomic handles to track transmission chains or distinguish outbreak clusters, the way public health authorities can with more variable viruses. Four broad phylogenetic groups do exist, loosely corresponding to geographic origin, but the differences between them are tiny by the standards of most virus families.

When to Worry and When to Wait

Mild, self-limiting flare-ups are common in carrier cats and do not always require antiviral treatment. A brief bout of sneezing and mild eye discharge in an otherwise eating, drinking, alert cat may resolve on its own within a week or two with supportive care alone. The situations that warrant prompt veterinary attention include corneal ulceration (squinting, holding one eye shut, cloudiness of the eye surface), refusal to eat for more than 24 hours, high fever, thick colored nasal or ocular discharge suggesting secondary bacterial infection, and any sign of respiratory distress such as open-mouth breathing. Kittens under eight weeks old and cats with compromised immune systems (such as those with concurrent feline immunodeficiency virus infection) are at higher risk for severe outcomes and should be seen sooner rather than later.

Chronic sequelae deserve monitoring too. Cats that have had multiple bouts of herpes-related eye disease may develop corneal sequestra (dark, dead patches of corneal tissue) or adhesions between the conjunctiva and the cornea called symblepharon. These complications sometimes require surgical intervention and can permanently affect vision. Keeping a log of flare-up frequency and severity helps your vet decide when to shift from reactive treatment to a more proactive maintenance strategy, which might include intermittent courses of famciclovir during known stressful periods like boarding or a household move.